Vectus Biosystems Limited (ASX:VBS)
Australia flag Australia · Delayed Price · Currency is AUD
0.1050
0.00 (0.00%)
Oct 9, 2026, 3:05 PM AEST

Vectus Biosystems Revenue

In the fiscal year ending June 30, 2026, Vectus Biosystems had annual revenue of 2.77M AUD with 478.66% growth. Vectus Biosystems had revenue of 2.76M in the half year ending June 30, 2026, with 463.01% growth. That makes Vectus Biosystems the 42,415th largest company in the world by revenue and 882nd in Australia.

Revenue
2.77M
Revenue Growth
+478.66%
P/S Ratio
2.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20262.77M2.29M478.66%
Jun 30, 2025478.18K-660.49K-58.01%
Jun 30, 20241.14M-215.86K-15.94%
Jun 30, 20231.35M54.45K4.19%
Jun 30, 20221.30M282.09K27.71%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immuron7.71M
Acrux6.58M
Tissue Repair2.99M
Cynata Therapeutics1.71M
Bio-Gene Technology1.08M
Nexalis Therapeutics1.07M
Biotron525.87K
AdAlta404.25K
Revenue Rankings